Pheast Therapeutics

Pheast is a pre-clinical stage immuno-oncology company focused on targeting cancer immune evasion pathways to activate the innate immune system in the fight against cancer. 

Italy parachute alps mountain paraglide
Biotech

NIH leaders join health agency exodus—Chutes & Ladders

NIH leaders join health agency exodus. Boehringer snatches up LEO exec for U.S. pharma team. Pharma vet flows into Ventus as CMO.
Darren Incorvaia , Zoey Becker Feb 21, 2025 8:30am
Parachute

New year, new C-suite execs—Chutes & Ladders

Jan 6, 2023 9:30am
graphic of a man with money identifying new ideas

Arch raises nearly $3B amid cratering biotech market

Jun 29, 2022 11:15am
Role of hundred dollar bills on other bills

Catalio reloads with $381M after financing Octant, Pheast

May 4, 2022 9:21am